ZINZINO AB (PUBL.): Preliminary sales report November 2025

Zinzino group revenue increased with a total of 45 %, compared with the previous year.

 

The revenue in November for Zinzino's sales markets increased by 49 % and amounted to SEK 375.0 (251.8) million. Faun Pharma's external sales decreased and amounted to SEK 4.3 (10.1) million. Overall, the Group increased revenues by 45 % to SEK 379.3 (261.9) million compared with the previous year.

Accumulated revenue for January – November 2025 increased by 54 % to SEK 3,007.5 (1,955.1) million.

 

Revenues were distributed as follows:

Regions,MSEK	25-Nov	24-Nov	Change	YTD 2025	YTD 2024	Change
The Nordics	29.7	29.0	2%	301.0	272.3	11%
Central Europe	133.9	70.4	90%	892.2	518.7	72%
East Europe	51.5	51.6	0%	361.9	366.0	-1%
South & West Europe	58.7	45.3	30%	513.9	346.7	48%
The Baltics	17.3	16.1	7%	115.4	95.6	21%
North America	58.1	25.8	125%	491.0	179.2	174%
Asia-Pacific	23.0	11.1	107%	263.7	64.4	309%
Africa	2.8	2.5	12%	21.1	15.1	40%
Zinzino	375.0	251.8	49%	2960.2	1858.0	59%
Faun Pharma	4.3	10.1	-57%	47.3	97.1	-51%
Zinzino Group	379.3	261.9	45%	3007.5	1955.1	54%

 

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

-Central Europe: Austria, Germany, Switzerland

-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

-The Baltics: Estonia, Latvia, Lithuania

-North America: Canada, USA, Mexico

-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea

-Africa: South Africa

 

For more information:

Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com

Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com

 

Pictures for publication free of charge: marketing@zinzino.com

 

Certified Adviser: DNB Carnegie Investment Bank AB (publ.)